Rheumatology franchise is slowly dying

We do not have much of a “portfolio” when we manufacturer 3 TNFs, and only get to market one of the three. We are 100% all in for Aria, and are letting Remicade and Simponi die off slowly. Basically, 2/3 of our TNF “portfolio” is a competitor with Aria. Same mechanism of action competing for the exact same patients with the exact same indications with the exact same customers.

Stelara is a joke. There is a huge class of trade issue the company chooses to ignore. The heavy usage comes from GI docs. The Rheum reps putting up good stelara numbers are getting the business from GI sales by luck of the class of trade. If the GI doc refers to Rheum for the in office dose, or fi it is a mixed account, then the rheum reps wins the class of trade game.

Now onto budget. We begin by cutting the sales force in half. Then we eliminate samples. Then we reduce the budget to about one lunch per week.

Now onto the real issue… We used to be the leader in office support services, and care path imploded our business and reputation. Our budget money is shifted to Xcenda reps to try and fix Care path issues. The previous 10-15 years we had access one, there were no xcenda reps and everything worked fine. Now Care path can’t do anything right at its one-year anniversary.

Congrats to the home office leadership team for self-imploding this franchise on your pit stop to another job in 18-24 months!

 

The management there is the laughing stock of the whole industry. What the Heck, Man!

 

We are not done yet. First we outsourced Simponi to Exogen and made them your competitor. Next, once Tremfya is approved we will take stelara and outsource it to another company to also make them your competitor.

Good selling!
Marti Heckman and Jeanne

 

Home office marketing: Let me guess, young , inexperienced MBAs who avoid the field and real life circumstance to the best of their abilities and then complain that sales can't move the product under their "brilliant" marketing plan? They sell each other really well.

 

Nah. Let me guess, lazy ass sales reps with no skills since they can’t sell without lunches and samples and blame their shit on marketing. Please, put up some numbers or move out. Home Depot is always hiring.

 

Naah, more like an incompetent marketing team that knows nothing about marketing. Where do the find these incompetents? Damn pathetic.

 

LOL. Can't sell without ACCESS, bro. Better get yourself to Home Depot before all us reps take your future job.

 

Under JoeyV's leadership, CarePath went to sh*t. So let's put him in charge of CV. WTF?!?!

 

Sure you can. That’s just beyond your limited skill sets. Bro.

 

Uh huh. Keep telling yourself that. I'll look for you in the paint department.

 

Updated Rep Core Competencies rolling out in 2020: Telepathy, invisibility cloaking, and ability to turn back time.

 

We are about to put a final nail into this coffin. I was able to pick up all of your cancelled lunches just in time for the launch of our new JAK, that has industry leading data. All of your products for RA have the MTX limitation, and no head to head data. We took on the #1 selling drug in the world and showed superiority + ACR 20 scores in the 70s', and ACR 50 scores in the 50s'. We have one more product to launch next year that will give us 3 different MOAs in the rheumatology office. We will be a true "portfolio" company in the immunology space as you are very committed to having 3 TNFs used with MTX. Good luck hitting your Aria number now that is already behind forecast.

 

Are you prepared to have your sales depleted with our portfolio of products?

Abbvie Rep

 

Yes. Long-timers here are used to having our clocks cleaned.

 

Is the Sou Cal manager still that gay guy named Ted? That guy would constantly check out guys crotches. It was disgusting that he was never chastised for that inappropriate behavior. Every guy in the room would put his iPad on his crotch and the guy was still tying to sneak a peek. I hope they run his ass out.

 

Its really sad working for Janssen these days. There are more Syneos rheum representatives than Janssen hires. The company bought a load of crud with this Jet thing. They are expecting us to make 6 calls on one of my targets in a month. This doesn’t even count how many calls the Syneos rep has to make.

 

It's funny to look back in hindsight.

Stelara sales up, Simponi stable, and Tremfya doing really well. Even Remicade is holding up decently.

Rumors of our decline have been greatly exaggerated. Just another who couldn't cut it and spreading fear.